Stephen D. Rubin

Oncology
1250 S Collegeville Rd
Collegeville, PA 19426

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial.

Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial.

Journal: Haematologica
Published: January 17, 2018
Showing 1-1 of 1

Last Updated: 09/26/2026